Lv4
690 积分 2025-08-08 加入
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas
3个月前
已完结
Leveraging Artificial Intelligence in GPCR Activation Studies: Computational Prediction Methods as Key Drivers of Knowledge
4个月前
已关闭
Predicting the Pharmacokinetics of T‐Cell Engagers as a Function of Target‐Mediated Drug Disposition
5个月前
已关闭
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
7个月前
已完结
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy
9个月前
已完结
Precision treatment with artificial intelligence assisted subtyping enhances therapeutic efficacy in HR+/HER2− breast cancer: The LINUXtrial
9个月前
已完结
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
9个月前
已完结
Design of a potent interleukin-21 mimic for cancer immunotherapy
9个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
10个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
11个月前
已完结
皖公网安备34019202002308
